Guest guest Posted November 7, 2008 Report Share Posted November 7, 2008 This was the first time I have ever seen LDN included in a CEU for medical professionals. Those old timers here remember that I said this study was a good first step but there were going to be problems with the scale they used. Well voila. The manufacturers of copaxone have supported this "independent educational activity". Look what the second to the last line says: "These results suggest that whereas naltrexone can improve the mental state of patients with MS, physical quality of life measures are not improved. " Lies and numbers. The study did not say there was no physical quality of life measurements improved, IT DIDN'T STUDY THAT. HELLO. We have our foot in the door The next step should be a large double blinded placebo controlled study with a bivarient cross over. Will this happen, no in mho. Why, who would volunteer to be part of the placebo group. I know I wouldn't, I know I would not recommend anyone to be, Why: I know it works. Why take the chance? Secondly, who is going to pay for it. Teva, etal ya right. At least we are being noticed. Dr. Skip Low-dose Opiate Agonists Improve Mental but not Physical MS Quality of Life Mixed results regarding quality of life in patients with MS were presented from a small (n = 80), single center, randomized, double-blind, placebo-controlled, crossover study of naltrexone.[10] In low doses, naltrexone has partial opiate agonist properties with purported effects on quality of life. Using a naltrexone 4.5-mg once-daily regimen, the 17-week study showed quality-of-life benefits for all mental health subscales of the Multiple Sclerosis Quality of Life Inventory relative to placebo, but there was no improvement in physical quality-of-life measures. Regarding mental health quality of life, naltrexone significantly improved the mental health component summary score of the Short Form (SF)-36, the Mental Health Inventory, the Pain Effects Scale, and the Perceived Deficits Questionnaire. These results suggest that whereas naltrexone can improve the mental state of patients with MS, physical quality of life measures are not improved. The investigators recommended further studies. This activity is supported by an independent educational grant from Teva. AOL Search: Your one stop for directions, recipes and all other Holiday needs. Search Now. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.